0001179110-18-009415.txt : 20180703
0001179110-18-009415.hdr.sgml : 20180703
20180703193350
ACCESSION NUMBER: 0001179110-18-009415
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180228
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wolff Henry Ward
CENTRAL INDEX KEY: 0001302390
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51531
FILM NUMBER: 18939120
MAIL ADDRESS:
STREET 1: 6701 KAISER DRIVE
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001061027
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943295878
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-266-3500
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980709
4
1
edgar.xml
FORM 4 -
X0306
4
2018-02-28
0
0001061027
SUNESIS PHARMACEUTICALS INC
SNSS
0001302390
Wolff Henry Ward
SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BLVD., SUITE 400
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
6.80
2018-02-28
4
A
0
37500
0
A
2028-02-28
Common Stock
37500
37500
D
Stock Option (Right to Buy)
2.12
2018-06-29
4
A
0
6250
0
A
2028-06-29
Common Stock
6250
6250
D
The option shall vest and become exercisable in twenty-four (24) equal monthly installments over a two (2) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
/s/William P. Quinn (Attorney-in-Fact)
2018-07-02